{"result": "(\"entity\"<|>AMERICAN DIABETES ASSOCIATION<|>ORGANIZATION<|>The American Diabetes Association is an organization that provides standards of medical care in diabetes and addresses complications related to diabetes management.)\n##\n(\"entity\"<|>DIABETES MELLITUS TYPE 1<|>EVENT<|>Diabetes Mellitus Type 1 is a chronic condition that requires careful management to prevent complications such as diabetic neuropathy.)\n##\n(\"entity\"<|>DIABETES MELLITUS TYPE 2<|>EVENT<|>Diabetes Mellitus Type 2 is a chronic condition that can lead to complications like diabetic neuropathy if not managed properly.)\n##\n(\"entity\"<|>NEUROPATHY<|>EVENT<|>Neuropathy refers to a range of disorders affecting the nerves, often associated with diabetes, leading to various clinical manifestations.)\n##\n(\"entity\"<|>CARDIOVASCULAR DISEASE<|>EVENT<|>Cardiovascular disease encompasses a range of conditions affecting the heart and blood vessels, which are more prevalent in individuals with diabetes.)\n##\n(\"relationship\"<|>AMERICAN DIABETES ASSOCIATION<|>DIABETES MELLITUS TYPE 1<|>The American Diabetes Association provides guidelines and standards for managing Diabetes Mellitus Type 1<|>8)\n##\n(\"relationship\"<|>AMERICAN DIABETES ASSOCIATION<|>DIABETES MELLITUS TYPE 2<|>The American Diabetes Association provides guidelines and standards for managing Diabetes Mellitus Type 2<|>8)\n##\n(\"relationship\"<|>DIABETES MELLITUS TYPE 1<|>NEUROPATHY<|>Diabetes Mellitus Type 1 can lead to neuropathy if glucose control is not optimized<|>7)\n##\n(\"relationship\"<|>DIABETES MELLITUS TYPE 2<|>NEUROPATHY<|>Diabetes Mellitus Type 2 can lead to neuropathy if glucose control is not optimized<|>7)\n##\n(\"relationship\"<|>NEUROPATHY<|>CARDIOVASCULAR DISEASE<|>Neuropathy is a complication that can be associated with cardiovascular disease in diabetic patients<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: habitualmente al tratamiento con inhibidores de la enzima de conversión.\nD. La mejoría del control glucémico con insulina es más eficaz que si se obtiene con antidiabéticos orales para el alivio de los síntomas de la neuropatía diabética.\n\n### COMENTARIO\n\nLas neuropatías diabéticas son un grupo heterogéneo de trastornos con diversas manifestaciones clínicas. Se debe optimizar el control de la glucosa para prevenir o retrasar el desarrollo de la neuropatía en pacientes con DM1 y para retardar la progresión de la neuropatía en pacientes con DM2. El tratamiento específico para el daño nervioso subyacente, que no sea un control glucémico mejorado, actualmente no está disponible.\n\nLa neuropatía diabética es un diagnóstico de exclusión. Las neuropatías no diabéticas pueden estar presentes en pacientes con diabetes y pueden ser tratables.\n\nHasta el 50% de las neuropatías periféricas diabéticas pueden ser asintomáticas. Si no se reconoce y si no se implementa el cuidado preventivo de los pies, los pacientes corren el riesgo de sufrir lesiones en los pies insensibles.\n\nEn cuanto a la neuropatía autonómica diabética, las principales manifestaciones clínicas son: falta de conciencia de hipoglucemia, taquicardia en reposo, hipotensión ortostática, gastroparesia, estreñimiento, diarrea, incontinencia fecal, disfunción eréctil, vejiga neurógena y disfunción sudomotora con aumento o disminución de la sudoración.\n\nLa neuropatía autonómica cardíaca (CAN) se asocia con la mortalidad independientemente de otros factores de riesgo cardiovascular. En sus primeras etapas, la CAN puede ser completamente asintomática y detectarse solo por la disminución de la variabilidad de la frecuencia cardíaca con la respiración profunda. La enfermedad avanzada puede asociarse con taquicardia en reposo (>100 lpm) e hipotensión ortostática (una caída en la presión arterial sistólica o diastólica de más de 20 mmHg o más de 10 mmHg, respectivamente, a la bipedestación sin un aumento apropiado en la frecuencia cardíaca). El tratamiento de la CAN generalmente se enfoca en aliviar los síntomas.\n\nReferencias:\n- American Diabetes Association. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S124-38.\n\n## 52 En la evaluación de la polineuropatía diabética, señale la respuesta falsa:\n\nA. Se evalúa la función de las fibras gruesas mediante un diapasón de 128 Hz.\nB. Se evalúa la función de las fibras gruesas mediante la valoración de la sensibilidad térmica.\nC. Se trata de un diagnóstico de exclusión.\nD. Se evalúa la función de las fibras finas mediante la valoración de la sensibilidad algésica (Pinprick).\n\n### COMENTARIO\n\nLa neuropatía diabética es un diagnóstico de exclusión. Las neuropatías no diabéticas pueden estar presentes en pacientes con diabetes y pueden ser tratables.\n\nLas siguientes pruebas clínicas se pueden usar para evaluar la función de las fibras grandes y pequeñas y la sensación de protección:\n\n1. Función de pequeña fibra: pinchazo y sensación de temperatura.\n2. Función de fibra grande: percepción de vibración y monofilamento de 10 g.\n3. Sensación protectora: monofilamento de 10 g.\n\nEstas pruebas no solo detectan la presencia de disfunción, sino que también predicen el riesgo futuro de complicaciones.\n\nReferencias:\n- American Diabetes Association. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S124-38.\n---\n## 53 En relación con la enfermedad cardíaca en el diabético, indique cuál de las siguientes afirmaciones es verdadera:\n\nA. La mortalidad del infarto de miocardio en un diabético es similar a la de un no diabético.\nB. La diabetes se asocia con un incremento de la insuficiencia cardíaca, incluso tras ajustar con otros factores de riesgo como presión arterial, nivel de colesterol y edad.\nC. La reducción de los niveles de colesterol LDL apenas produce beneficio clínico para disminuir eventos cardiovasculares en los pacientes con diabetes.\nD. Los betabloqueantes no deberían ser utilizados en el tratamiento de un síndrome coronario agudo en pacientes con diabetes.\n\n### COMENTARIO\n\nLas personas con diabetes tienen un riesgo incrementado de complicaciones cardiovasculares, entre ellas el infarto agudo de miocardio (IAM). Aunque el pronóstico de la enfermedad coronaria ha mejorado en el contexto de los avances de la cardiología intervencionista, las personas con diabetes siguen teniendo una mortalidad superior tras un IAM, mediada, en parte, por una\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}